Brazilian lung cancer study aims to bridge treatment gaps
NCT ID NCT07109154
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at the real-world treatment of advanced non-small cell lung cancer (NSCLC) in Brazil. Researchers will review medical records of 200 patients and survey doctors to see if treatments follow national guidelines. The goal is to understand patient demographics and improve care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED NON-SMALL CELL LUNG CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
ACTIVE_NOT_RECRUITINGRecife, Brazil
-
Research Site
RECRUITINGRio de Janeiro, Brazil
-
Research Site
NOT_YET_RECRUITINGRio de Janeiro, Brazil
-
Research Site
RECRUITINGSalvador, Brazil
-
Research Site
NOT_YET_RECRUITINGSalvador, Brazil
-
Research Site
ACTIVE_NOT_RECRUITINGSão Paulo, Brazil
-
Research Site
NOT_YET_RECRUITINGSão Paulo, Brazil
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New strategies aim to boost lung cancer screening and save lives
- 3D lung models could help patients choose the right surgery
- AI-Powered navigation aims to pinpoint tiny lung nodules during surgery
- Default option nudge may boost cancer screening in High-Risk groups
- Nanoparticle chemo and DNA-Repair blocker join forces against tough cancers
- Blood test could reveal how lung cancer evolves during treatment